FUS and amyotrophic lateral sclerosis: We examined the steady-state localization of the R521G/S2 and P525L/S2 mutants using immunocytochemistry and found that SGG2 mutations do not impact the cytoplasmic localization caused by the ALS-FUS mutations (Fig. 7B).